What's moving the markets on Monday?

The FTSE, along with its European peer are heading for a higher start boosted by vaccine optimism and ahead of a key day in Parliament for the Internal Markets Bill.

Charts (2)

The FTSE, along with its European peer are heading for a higher start boosted by vaccine optimism and ahead of a key day in Parliament for the Internal Markets Bill.

Vaccine trials restart
Over the weekend, Oxford University announced that the joint AstraZeneca covid vaccine trial will restart this week after a routine pause n the previous week. News that the trial is back on track is music to the ears of the market. A vaccine is the surest and quickest, and possibly the only way for the economy to recover to pre-pandemic growth levels. The vaccine news comes as the “Rule of 6” comes into force in the UK, banning meetings of groups of over 6. AstraZeneca shares are on the rise in early trade. 
Adding to the upbeat vaccine news Pfizer In Chief executive officer Albert Bourla said its likely that a covid vaccine will be deployed in the US by the end of the year. A more optimistic view than health authorities. 

Internal Markets Bill debate
Markets and the Pound are braced for another big Brexit week. The controversial internal markets bill will start to be discussed today in the House of Commons. It is not certain whether the bill will make it through the Commons or even the Lords given that it breaks international law. However, if it does clear Parliaments the Justice Secretary Robert Buckland has already said he will resign. The Pound was the worst performer across the previous week, shedding 3.7% versus the USD in its worst weekly performance since early March. GBP is one of the of performing majors this morning ahead of the debate.

Whilst the 8th round of Brexit talks ended with unsurprisingly little progress, informal Brexit talks are set to continue across the week, ahead of the 9th round beginning on 25th September.

TikTok to partner Oracle, Nvidia buys ARM
Rumours are swirling that TiKTok is choosing to partner up with Oracle rather than Microsoft. Microsoft hasn’t been asked to revise its initial offer amid opposition to the deal from the Chinese government. Has Microsoft managed to dodge a bullet? Could be so according to Bloomberg reports that the deal no longer includes key underlying technologies and the prospect of Chinese government approval is unclear at best.

Nvidia has agreed to buy ARM Holding, SoftBank’s chip division for $40 billion 4 years after the Japanese bank bought it for $32 billion.

Eurozone industrial production
Looking ahead, Eurozone industrial production data will provide some clues as to the health of the sector. Expectations are for growth 10% mom in July, up from 9.1% in June as the sector outperforms services in its recovery. 

FTSE Chart
The FTSE is continuing its rebound from Sept 3rd lows, pishing above 50,100 and 200 sma on 4 hr chart. Immediate resistance can be seen at 6110 prior to 6180 (high 25th Aug).
Support can be seen at 6030 200 sma, prior to 5980 (100sma).


More from FTSE 100

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.